---
annotation-target: 1-s2.0-S0006497122010667-main.pdf
---


>%%
>```annotation-json
>{"created":"2022-09-15T02:54:44.147Z","updated":"2022-09-15T02:54:44.147Z","document":{"title":"Leukemia inhibitory factor protects against graft-versus-host disease while preserving graft-versus-leukemia activity","link":[{"href":"urn:x-pdf:e2a9624af4dc21e55a36b962e36cfcb0"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf"}],"documentFingerprint":"e2a9624af4dc21e55a36b962e36cfcb0"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf","selector":[{"type":"TextPositionSelector","start":3083,"end":3110},{"type":"TextQuoteSelector","exact":"Leukemia inhibitory factor ","prefix":"ration information (if any): 1  ","suffix":"protects against graft-versus-ho"}]}]}
>```
>%%
>*%%PREFIX%%ration information (if any): 1%%HIGHLIGHT%% ==Leukemia inhibitory factor== %%POSTFIX%%protects against graft-versus-ho*
>%%LINK%%[[#^tbii6qum5jh|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^tbii6qum5jh


>%%
>```annotation-json
>{"created":"2022-09-15T02:55:54.154Z","updated":"2022-09-15T02:55:54.154Z","document":{"title":"Leukemia inhibitory factor protects against graft-versus-host disease while preserving graft-versus-leukemia activity","link":[{"href":"urn:x-pdf:e2a9624af4dc21e55a36b962e36cfcb0"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf"}],"documentFingerprint":"e2a9624af4dc21e55a36b962e36cfcb0"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf","selector":[{"type":"TextPositionSelector","start":4754,"end":5095},{"type":"TextQuoteSelector","exact":" Here, we report an unexpected role of cytokine leukemia inhibitory factor (LIF) in 28 protecting against GVHD development.  Administrating recombinant LIF protein (rLIF) protects 29 mice from GVHD-induced tissue damage and lethality without compromising the graft-versus-30 leukemia (GVL) activity, which is crucial to prevent tumor relapse","prefix":"ncies  and  blood 27 disorders. ","suffix":".  We found that rLIF reduces 31"}]}]}
>```
>%%
>*%%PREFIX%%ncies  and  blood 27 disorders.%%HIGHLIGHT%% ==Here, we report an unexpected role of cytokine leukemia inhibitory factor (LIF) in 28 protecting against GVHD development.  Administrating recombinant LIF protein (rLIF) protects 29 mice from GVHD-induced tissue damage and lethality without compromising the graft-versus-30 leukemia (GVL) activity, which is crucial to prevent tumor relapse== %%POSTFIX%%.  We found that rLIF reduces 31*
>%%LINK%%[[#^9pg6mvnc8p5|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^9pg6mvnc8p5


>%%
>```annotation-json
>{"created":"2022-09-15T02:59:07.535Z","updated":"2022-09-15T02:59:07.535Z","document":{"title":"Leukemia inhibitory factor protects against graft-versus-host disease while preserving graft-versus-leukemia activity","link":[{"href":"urn:x-pdf:e2a9624af4dc21e55a36b962e36cfcb0"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf"}],"documentFingerprint":"e2a9624af4dc21e55a36b962e36cfcb0"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf","selector":[{"type":"TextPositionSelector","start":6092,"end":6678},{"type":"TextQuoteSelector","exact":" However, 44 this treatment is often limited by the development of GVHD.  Acute GVHD is mainly induced 45 by  the  antigen  disparity  between  donor  and  recipient  1-3.    The  alloreactive  donor  T  cells,  46 activated  by  host  antigen-presenting  cells  (APCs),  cause  damage  in  vital  recipient  organs, 47 classically the gastrointestinal (GI) tract, skin and liver, and initiate GVHD 1.  GVHD affects up 48 to  70%  of  allo-BMT  patients,  with  20%  to  75%  mortality  rates  4.  Limiting  GHVD  while 49 maintaining GVL activity remains a critical goal in the clinic.","prefix":"e cell-mediated GVL effect 1-3. ","suffix":" 50 The GI tract is the main org"}]}]}
>```
>%%
>*%%PREFIX%%e cell-mediated GVL effect 1-3.%%HIGHLIGHT%% ==However, 44 this treatment is often limited by the development of GVHD.  Acute GVHD is mainly induced 45 by  the  antigen  disparity  between  donor  and  recipient  1-3.    The  alloreactive  donor  T  cells,  46 activated  by  host  antigen-presenting  cells  (APCs),  cause  damage  in  vital  recipient  organs, 47 classically the gastrointestinal (GI) tract, skin and liver, and initiate GVHD 1.  GVHD affects up 48 to  70%  of  allo-BMT  patients,  with  20%  to  75%  mortality  rates  4.  Limiting  GHVD  while 49 maintaining GVL activity remains a critical goal in the clinic.== %%POSTFIX%%50 The GI tract is the main org*
>%%LINK%%[[#^tb8ibyfjaf|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^tb8ibyfjaf


>%%
>```annotation-json
>{"created":"2022-09-15T03:20:01.131Z","updated":"2022-09-15T03:20:01.131Z","document":{"title":"Leukemia inhibitory factor protects against graft-versus-host disease while preserving graft-versus-leukemia activity","link":[{"href":"urn:x-pdf:e2a9624af4dc21e55a36b962e36cfcb0"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf"}],"documentFingerprint":"e2a9624af4dc21e55a36b962e36cfcb0"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf","selector":[{"type":"TextPositionSelector","start":6682,"end":7431},{"type":"TextQuoteSelector","exact":"The GI tract is the main organ targeted by donor T cells during GVHD.  Damage to the 51 GI tract is the primary determinant of GVHD severity and lethality 5.  Shortly after allo-BMT, 52 donor T cells migrate to the GI tract, and preferentially invade the crypt ISC compartment, where 53 they damage ISCs, leading to GI injury and GVHD 6.  A recent study revealed that the elevation 54 of cytokine interleukin 12 (IL12) levels by irradiation before allo-BMT contributes to GI injury 55 during GVHD development 5.  The elevation of IL12 induces major histocompatibility complex 56 class II (MHC-II) expression on the surface of intestinal epithelial cells (IECs), which serve as 57 APCs to activate donor T cells to induce GI injury and trigger GVHD 5","prefix":"critical goal in the clinic. 50 ","suffix":".   58 LIF was initially identif"}]}]}
>```
>%%
>*%%PREFIX%%critical goal in the clinic. 50%%HIGHLIGHT%% ==The GI tract is the main organ targeted by donor T cells during GVHD.  Damage to the 51 GI tract is the primary determinant of GVHD severity and lethality 5.  Shortly after allo-BMT, 52 donor T cells migrate to the GI tract, and preferentially invade the crypt ISC compartment, where 53 they damage ISCs, leading to GI injury and GVHD 6.  A recent study revealed that the elevation 54 of cytokine interleukin 12 (IL12) levels by irradiation before allo-BMT contributes to GI injury 55 during GVHD development 5.  The elevation of IL12 induces major histocompatibility complex 56 class II (MHC-II) expression on the surface of intestinal epithelial cells (IECs), which serve as 57 APCs to activate donor T cells to induce GI injury and trigger GVHD 5== %%POSTFIX%%.   58 LIF was initially identif*
>%%LINK%%[[#^erldjzdjoc4|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^erldjzdjoc4


>%%
>```annotation-json
>{"created":"2022-09-15T03:24:00.748Z","updated":"2022-09-15T03:24:00.748Z","document":{"title":"Leukemia inhibitory factor protects against graft-versus-host disease while preserving graft-versus-leukemia activity","link":[{"href":"urn:x-pdf:e2a9624af4dc21e55a36b962e36cfcb0"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf"}],"documentFingerprint":"e2a9624af4dc21e55a36b962e36cfcb0"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf","selector":[{"type":"TextPositionSelector","start":27222,"end":27277},{"type":"TextQuoteSelector","exact":"rLIF regulates IL12 in DCs through the STAT1 signaling.","prefix":"fect of LIF on GVHD.   282  283 ","suffix":" 284 To study the mechanism wher"}]}]}
>```
>%%
>*%%PREFIX%%fect of LIF on GVHD.   282  283%%HIGHLIGHT%% ==rLIF regulates IL12 in DCs through the STAT1 signaling.== %%POSTFIX%%284 To study the mechanism wher*
>%%LINK%%[[#^xmhxhj13wb|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^xmhxhj13wb


>%%
>```annotation-json
>{"created":"2022-09-15T03:24:43.306Z","updated":"2022-09-15T03:24:43.306Z","document":{"title":"Leukemia inhibitory factor protects against graft-versus-host disease while preserving graft-versus-leukemia activity","link":[{"href":"urn:x-pdf:e2a9624af4dc21e55a36b962e36cfcb0"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf"}],"documentFingerprint":"e2a9624af4dc21e55a36b962e36cfcb0"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf","selector":[{"type":"TextPositionSelector","start":27988,"end":28403},{"type":"TextQuoteSelector","exact":" 7.  We examined a panel of well-known LIF downstream pathways, 292 including the STATs, AKT, ERK and MAPK pathways 7, in BMDCs derived from C57BL/6 and 293 B6C3F1 upon IFNγ and LPS stimulation.  rLIF greatly enhanced STAT1 activity as reflected by 294 the increased levels of STAT1 phosphorylation at Tyr-701 (p-STAT1) but not the total STAT1 295 protein levels in BMDCs treated with IFNγ and LPS (Fig.  5j&S10a). ","prefix":"d 291 cell-type specific manner ","suffix":" No clear activation of 296 16  "}]}]}
>```
>%%
>*%%PREFIX%%d 291 cell-type specific manner%%HIGHLIGHT%% ==7.  We examined a panel of well-known LIF downstream pathways, 292 including the STATs, AKT, ERK and MAPK pathways 7, in BMDCs derived from C57BL/6 and 293 B6C3F1 upon IFNγ and LPS stimulation.  rLIF greatly enhanced STAT1 activity as reflected by 294 the increased levels of STAT1 phosphorylation at Tyr-701 (p-STAT1) but not the total STAT1 295 protein levels in BMDCs treated with IFNγ and LPS (Fig.  5j&S10a).== %%POSTFIX%%No clear activation of 296 16*
>%%LINK%%[[#^re9ep75a58|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^re9ep75a58


>%%
>```annotation-json
>{"created":"2022-09-15T03:27:35.623Z","updated":"2022-09-15T03:27:35.623Z","document":{"title":"Leukemia inhibitory factor protects against graft-versus-host disease while preserving graft-versus-leukemia activity","link":[{"href":"urn:x-pdf:e2a9624af4dc21e55a36b962e36cfcb0"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf"}],"documentFingerprint":"e2a9624af4dc21e55a36b962e36cfcb0"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf","selector":[{"type":"TextPositionSelector","start":33583,"end":34044},{"type":"TextQuoteSelector","exact":"Allo-T cells infiltrate into recipient tissues post allo-BMT and get activated by APCs, 354 which leads to inflammation and subsequent tissue damage and lethality in GVHD 5.  A recent 355 study reported that IECs act as APCs to induce donor T cell activation and GVHD initiation 5. 356 Here,  we  demonstrated  that  rLIF  reduced  the  inflammation  and  donor  T  cell  infiltration  in 357 GVHD.  IL12 is a key inflammatory cytokine and inducer of GVHD 5,44.","prefix":"le of LIF 352 in GVHD.  353 19  ","suffix":"  Our results showed 358 that rL"}]}]}
>```
>%%
>*%%PREFIX%%le of LIF 352 in GVHD.  353 19%%HIGHLIGHT%% ==Allo-T cells infiltrate into recipient tissues post allo-BMT and get activated by APCs, 354 which leads to inflammation and subsequent tissue damage and lethality in GVHD 5.  A recent 355 study reported that IECs act as APCs to induce donor T cell activation and GVHD initiation 5. 356 Here,  we  demonstrated  that  rLIF  reduced  the  inflammation  and  donor  T  cell  infiltration  in 357 GVHD.  IL12 is a key inflammatory cytokine and inducer of GVHD 5,44.== %%POSTFIX%%Our results showed 358 that rL*
>%%LINK%%[[#^andlvhevbiv|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^andlvhevbiv


>%%
>```annotation-json
>{"created":"2022-09-15T03:28:17.887Z","updated":"2022-09-15T03:28:17.887Z","document":{"title":"Leukemia inhibitory factor protects against graft-versus-host disease while preserving graft-versus-leukemia activity","link":[{"href":"urn:x-pdf:e2a9624af4dc21e55a36b962e36cfcb0"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf"}],"documentFingerprint":"e2a9624af4dc21e55a36b962e36cfcb0"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010667-main.pdf","selector":[{"type":"TextPositionSelector","start":34854,"end":35259},{"type":"TextQuoteSelector","exact":"  Here, we found that LIF 366 activated  STAT1  in  BMDCs  to  transcriptionally  repress  IL12-p40.    These  results  suggest  a 367 cell/tissue-type  and  context-specific  role  of  LIF  in  regulating  its  downstream  pathways  to 368 modulate  different  biological  and  pathological  processes.    STAT1  knockout  mice  can  be 369 employed to validate the role of LIF in DCs in future studies. ","prefix":"ion in a mouse colitis model 50.","suffix":" 370 Despite GVHD, allo-T cells "}]}]}
>```
>%%
>*%%PREFIX%%ion in a mouse colitis model 50.%%HIGHLIGHT%% ==Here, we found that LIF 366 activated  STAT1  in  BMDCs  to  transcriptionally  repress  IL12-p40.    These  results  suggest  a 367 cell/tissue-type  and  context-specific  role  of  LIF  in  regulating  its  downstream  pathways  to 368 modulate  different  biological  and  pathological  processes.    STAT1  knockout  mice  can  be 369 employed to validate the role of LIF in DCs in future studies.== %%POSTFIX%%370 Despite GVHD, allo-T cells*
>%%LINK%%[[#^9ne15exatbk|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^9ne15exatbk
